Omeprazole and Ilevro drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Omeprazole (omeprazole) and Ilevro (nepafenac). Common drug interactions include joint swelling among females and cataract among males.
The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Ilevro. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
What is Ilevro?
Ilevro has active ingredients of nepafenac. eHealthMe is studying from 1,531 Ilevro users. Check the latest studies of Ilevro.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
58 people who take Omeprazole and Ilevro together, and have interactions are studied.

What are the common drug interactions of Omeprazole and Ilevro, by gender? *:
female:
- Joint swelling
- Tooth injury
- Wrist fracture
- Abdominal pain upper
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cardiac disorder
- Cataract (clouding of the lens inside the eye)
- Cellulitis (infection under the skin)
male:
- Cataract (clouding of the lens inside the eye)
- Fatigue (feeling of tiredness)
- Anaemia (lack of blood)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood bilirubin increased
- Blood pressure decreased
- Bradyarrhythmia (heart slowness)
- Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
- Drug ineffective
- Glycosylated haemoglobin increased
What are the common drug interactions of Omeprazole and Ilevro, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Decreased activity
- Depression
- Emotional distress
- Pain
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
50-59:
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Renal failure (kidney dysfunction)
- Hyperkalaemia (damage to or disease of the kidney)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Arthralgia (joint pain)
- Constipation
- Emotional distress
- Head discomfort
- Hypertension (high blood pressure)
60+:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Abdominal distension
- Abnormal dreams
- Anaemia (lack of blood)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood bilirubin increased
- Blood pressure decreased
- Bradyarrhythmia (heart slowness)
- Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
What are the existing conditions these people have? *
- High Blood Cholesterol: 11 people, 18.97%
- High Blood Pressure: 8 people, 13.79%
- Multiple Myeloma (cancer of the plasma cells): 7 people, 12.07%
- Pain: 7 people, 12.07%
- Immunodeficiency Common Variable: 6 people, 10.34%
- Diabetes: 6 people, 10.34%
- Stress And Anxiety: 4 people, 6.90%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.90%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 6.90%
- Memory Loss: 3 people, 5.17%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and Ilevro?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Omeprazole (410,631 reports)
- Ilevro (1,531 reports)
Browse all drug interactions of Omeprazole and Ilevro:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ilevro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Omeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ilevro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on omeprazole and nepafenac (the active ingredients of Omeprazole and Ilevro, respectively), and Omeprazole and Ilevro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pulmonary Embolism and Pulmonary Alveolar Haemorrhage - a second ago
- Drug interactions of Fluconazole and Lantus - 5 seconds ago
- Could Gilenya cause Precancerous Cells Present? - 7 seconds ago
- Drug interactions of Quetiapine Fumarate and Senna Alexandrina - 8 seconds ago
- Drug interactions of Melatonin and Pomalidomide - 9 seconds ago
- Could Skelaxin cause Muscle Spasms? - 10 seconds ago
- Could Metformin cause Bartholin'S Cyst? - 12 seconds ago
- Could Sandostatin Lar cause Pain Exacerbated? - 12 seconds ago
- Bone Loss and Uveitis - 13 seconds ago
- Could Rhinocort cause Thyroid Diseases? - 14 seconds ago